NCT03101631 (ELDERLY) is a NA clinical trial of Comprehensive Geriatric Assessment (CGA) in Fragility, sponsored by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana.

What drugs are being tested in NCT03101631?

Interventions in NCT03101631: Comprehensive Geriatric Assessment (CGA).

What condition does NCT03101631 study?

NCT03101631 studies Fragility, Cancer.

Is NCT03101631 still recruiting?

NCT03101631 is currently completed. Last updated 30 May 2017.

Last reviewed 2017-05-30 · How we verify

NCT03101631: ELDERLY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Frailty Evaluation in Elderly Population With Cancer

Completed NA Last updated 30 May 2017

What this trial tests

NA trial testing Comprehensive Geriatric Assessment (CGA) in Fragility in 62 participants. Completed in 30 January 2015.

Timeline

2 January 2014

Primary endpoint
30 July 2014

30 January 2015

Quick facts

Lead sponsor	Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	62
Start date	2 January 2014
Primary completion	30 July 2014
Estimated completion	30 January 2015

Drugs / interventions tested

Comprehensive Geriatric Assessment (CGA)

Conditions studied

Fragility — all drugs for Fragility →
Cancer — all drugs for Cancer →

Sponsor

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana — full company profile →

Who can join

70 and older, any sex, with Fragility or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Comprehensive Geriatric Assessment (CGA) is, still today, barely established in the standard practice. Although the different scientific societies recommend a CGA in elderly population affected with cancer at first visit, the evidence regarding its transcendence is limited. On the other hand, the components of this evaluation and the translation of their findings in changes in the clinical practice are not stablished. This project intends to implement a CGA in a group of patients to compare this group with an historical cohort that reflects the standard practice, to evaluate the differences between both approaches. The study also evaluate the feasibility and utility of this CGA. All these questions aims to support the hypothesis that CGA impacts on the cancer treatment for elderly population affected with cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Comprehensive Geriatric Assessment (CGA)

Trials testing the same drug.

NCT06761534 — Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patients · enrolling by invitation
NCT06890325 — A Service-Learning Program for Comprehensive Geriatric Assessment and Health Promotion in Older Adults · NA · recruiting

Other recruiting trials for Fragility

Currently open trials in the same condition.

NCT06911619 — Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool) · NA · recruiting
NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
NCT06286891 — Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients · recruiting
NCT06247358 — Frailty, Physical Capacity and Lung Function in Postoperative Cardiac Surgery Patients · recruiting
NCT06361615 — Effect of a Dual-task Intervention Program on Physical and Cognitive Function · NA · active not recruiting

Other Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana trials

Trials by the same sponsor.

NCT07391748 — Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers · EARLY_PHASE1 · not yet recruiting
NCT06888297 — RESCUE: European Certification for Second Victim Support · enrolling by invitation
NCT07005544 — Hand Hygiene Skills Using Virtual Reality · NA · completed
NCT06516276 — Technologies to Improve QoL of Prostate Cancer · NA · not yet recruiting
NCT06512480 — Colorectal Surgery, a New Robotic Platform (Hugo Ras) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03101631 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Last refreshed: 30 May 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03101631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing